Go Pro
NASDAQ:BMGL

Basel Medical Group Q2 2026 Earnings Report

Basel Medical Group logo
$5.76 +0.14 (+2.47%)
Closing price 03:56 PM Eastern
Extended Trading
$5.90 +0.14 (+2.45%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Basel Medical Group EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Basel Medical Group Revenue Results

Actual Revenue
$3.21 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Basel Medical Group Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Basel Medical Group Earnings Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
See More Basel Medical Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Basel Medical Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Basel Medical Group and other key companies, straight to your email.

About Basel Medical Group

Basel Medical Group (NASDAQ:BMGL). is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

View Basel Medical Group Profile